AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

Rttnews

Published November 9, 2026

PharmAla Biotech Signs MDMA Supply And Data Deal For Danish PTSD Trial; Shares Rise 10%

Read the full story at Rttnews

PharmAla Biotech Holdings Inc. (MDXXF), a biotechnology company focused on developing and manufacturing MDXX-class compounds, including MDMA ,.

Post on X

Share this story

Surfaced by this Google Alert

MDMA